• Patient must have pathologically confirmed breast cancer (per EMR).
• Patient with localized or advanced cancer (per EMR).
• Patient is on a waitlist of at least 2 weeks or more for MSK Counseling Center intake and will not complete a Counseling Center intake prior to intervention (these patients will be replaced) (per EMR, patient's care team, or self-report).
• Has no current active or passive suicidal ideation (per self-report of PHQ-9, Item 9: Thoughts that you would be better off dead, or of hurting yourself).
• Female (per EMR)
• Age 65 18 (per EMR)
• English fluency - Per self-report: How well do you speak English?
• Agrees to be audio-recorded (per self-report) NOTE: Participants who report Very well are considered fluent.
• Lives in New York, New Jersey, or Connecticut (per self-report).
• Has no significant psychiatric disturbance sufficient to preclude completion of the assessment measures, interview, or informed consent (i.e., acute psychiatric symptoms which require urgent or extended individual treatment) (per EMR, patient's care team, or study team).
• Has no presence of cognitive impairment disorder (i.e., delirium or dementia) sufficient to preclude meaningful informed consent and/or data collection (per EMR, patient's care team, or per self-report of BOMC cognitive test).
• Has no current active or passive suicidal ideation (per item 9 of the PHQ-9 and the CSSRS).

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety